What is it about?
This paper describes elevated ADAM10 levels in the cerebrospinal fluid and plasma form patients with mild Alzheimer's disease (AD), indicating the this protein can be a complimentary AD biomarker
Featured Image
Photo by Rod Long on Unsplash
Why is it important?
To diagnosis AD in its mild stage is crucial to better interventions to delay AD development.
Read the Original
This page is a summary of: ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer’s Disease, International Journal of Molecular Sciences, February 2021, MDPI AG,
DOI: 10.3390/ijms22052416.
You can read the full text:
Contributors
The following have contributed to this page
